glp 1 birth defects GLP-1 use during early pregnancy may not increase risk of major adverse outcomes Woman says she got pregnant

Not persisting with medication is a well known phenomenon with other conditions, such as type 2 diabetes, chronic obstructive pulmonary disease and hypertension

GLP-1R Signaling Directly Activates Arcuate Nucleus Kisspeptin Action in Brain Slices but Does not Rescue Luteinizing Hormone Inhibition in Ovariectomized Mice During Negative Energy Balance

The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects

The REWIND trial investigated the cardiovascular benefits of dulaglutide, a GLP-1 receptor agonist, in a population of 9,901 patients with T2DM aged 50+ and either established CVD or risk factors

Diabetes Metab Res Rev 34: e2982, 2018

10.3748/wjg.v30.i23.2964 66 SamsonS